Global General Anesthesia Drugs Sales Market Report 2020

SKU ID : QYR-16609984 | Publishing Date : 23-Oct-2020 | No. of pages : 143

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
General Anesthesia Drugs can be divided into two categories, Intravenous Anesthetics, accounting for 69.62% and Inhalational Anesthetics, accounting for 30.38%. Intravenous Anesthetics widely used drugs are: Propofol, Etomidate, Midazolam, Barbiturates (such as thiopental), and so on. Desflurane, Isoflurane and Sevoflurane are the most widely used Inhalational Anesthetics. Propofol hold the largest market share of General Anesthesia Drugs with 33.83% market share. Sevoflurane market share is over 21.17%, being the second largest market share of General Anesthesia Drugs.

Market Analysis and Insights: Global General Anesthesia Drugs Market
The global General Anesthesia Drugs market size is projected to reach US$ 8305.3 million by 2026, from US$ 7078.4 million in 2020, at a CAGR of 2.7% during 2021-2026.

Global General Anesthesia Drugs Scope and Market Size
The global General Anesthesia Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global General Anesthesia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the General Anesthesia Drugs market is segmented into
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others

Segment by Application, the General Anesthesia Drugs market is segmented into
Intravenous Anesthetics
Inhalational Anesthetics

The General Anesthesia Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the General Anesthesia Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and General Anesthesia Drugs Market Share Analysis
General Anesthesia Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in General Anesthesia Drugs business, the date to enter into the General Anesthesia Drugs market, General Anesthesia Drugs product introduction, recent developments, etc.

The major vendors covered:
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports